NICE (the National Institute for Health and Care Excellence) have recommended two coagulometers for use by people taking long-term anti-blood clotting therapy. The self-check machines, called CoaguChek XS and InRatio2 PT/INR, allow patients to monitor blood clotting in those taking long-term anti-blood clotting drugs (such as warfarin) to reduce their risk of blood clots.
NICE have recommended use of self-check machines for those who both prefer to use self-check machines rather than visit a hospital each time a check is needed and who are able to effectively use this type of monitoring. According to NICE, people (and their carers) who will be using one of these devices should be given training, and their doctor should regularly assess self-monitoring.
Roche Diagnostics’ CoaguChek INR machines (coagulation self-testing machines) allow blood coagulation levels to be monitored at home. Self-testing means that heart children can avoid regular hospital visits for coagulation monitoring.
Due to NICE’s recommendations CHF is encouraging parents, in the first instance, to ask their GP to provide an INR self-testing machine. Do get in touch if you have any problems or questions.
We call on CCGs and NHS England to take note of NICE’s recommendations and the accompanying costing statement. The latter notes that use of self-check coagulometers has the potential for cost-savings and the purchase of devices could be funded by CCGs or NHS England area teams.
If anyone received a CoaguChek XS meter from us since 2006 please read this patient letter from Roche.
Should you want to ask any additional questions and/or seek clarification please do contact Roche’s CoaguChek careline free on 0808 100 7666 (UK) or 1800 509 586 (Republic of Ireland), Monday to Friday 09.00 to 18.00.